These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 435362)

  • 21. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.
    Bhatavdekar JM; Balar DB; Shah NG; Trivedi SN; Bhaduri A; Patel DD; Karelia NH; Shukla MK; Ghosh N
    Tumour Biol; 1987; 8(5):233-40. PubMed ID: 3448770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
    Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
    Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
    Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
    Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
    Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
    Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinicopathological study on carcinoembryonic antigen in breast cancer].
    Asagoe T; Yamoto H; Hanatani Y; Horie F; Nemoto A; Kidooka K; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):793-8. PubMed ID: 2370434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.
    Mujagić Z; Mujagic H; Prnjavorac B
    Med Arh; 2004; 58(1):23-6. PubMed ID: 15017899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated carcinoembryonic antigen levels in the milk of a nursing mother with inoperable breast cancer.
    Bartal AH; Kahana L; Yarom J
    Cancer; 1980 Nov; 46(9):2091-2. PubMed ID: 6253050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of relationship between parity and level of carcinoembryonic antigen in women with breast cancer.
    Heller R; Fisher R; Nash A; Knapp J
    Anticancer Res; 1990; 10(6):1755-7. PubMed ID: 2285254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carcinoembryonic antigen in clinical disorders.
    Booth SN; King JP; Leonard JC; Dykes PW
    Gut; 1973 Oct; 14(10):794-9. PubMed ID: 4758660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
    Lokich JJ; Zamcheck N; Lowenstein MW
    Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
    Williams MR; Turkes A; Pearson D; Twining P; Griffiths K; Blamey RW
    Eur J Surg Oncol; 1988 Oct; 14(5):417-22. PubMed ID: 3181446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.
    Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E
    Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
    Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
    J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.